Vivodyne

VivodyneVivodyne
Vivodyne

Vivodyne

Vivodyne is developing advanced AI models for drug discovery and development.

Website
2021Active41
Rate
Advertise here

About

Vivodyne revolutionizes therapeutics development by providing preclinical human data before clinical trials. Their platform utilizes ultra-realistic, lab-grown human organ tissue models and predictive AI to accelerate the discovery and optimization of new therapies. They partner with biopharma companies to advance new targets and bring better therapeutics to patients.

Technology stack

detected 2026-07-02
CDN
Cloudflare
EmailGoogle Workspace
Stack
Webflow
Analytics
Google Analytics 4Google Tag Manager
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does Vivodyne do?

Vivodyne revolutionizes therapeutics development by providing preclinical human data before clinical trials. Their platform utilizes ultra-realistic, lab-grown human organ tissue models and predictive AI to accelerate the discovery and optimization of new therapies. They partner with biopharma companies to advance new targets and bring better therapeutics to patients.

How much funding has Vivodyne raised?

Vivodyne has raised a total of $118M in funding.

Where is Vivodyne headquartered?

Vivodyne is headquartered in New York, United States.

When was Vivodyne founded?

Vivodyne was founded in 2021.

What industry does Vivodyne operate in?

Vivodyne operates in AI Drug Discovery, Biotech, Foundation Model, Generative AI, Drug Discovery, Machine Learning.

How many employees does Vivodyne have?

Vivodyne has approximately 41 people on record.

What is Vivodyne's valuation?

StartupHub estimates Vivodyne's effective valuation at $439.2M (range $295.0M to $708.0M, 18% confidence), based on comparable companies in the sector.